“Development of BIBR1591 Derivatives with Enhanced Telomerase Inhibition, Specifically Compound 6f”

https://pubmed.ncbi.nlm.nih.gov/38117230

The abstract reports the development of new BIBR1591 derivatives with improved telomerase inhibition activity, particularly compound 6f which showed the highest inhibition (63.14%).